Cargando…

Therapeutic host-directed strategies to improve outcome in tuberculosis

Bacille Calmette-Guérin (BCG) is the only licenced tuberculosis (TB) vaccine, but has limited efficacy against pulmonary TB disease development and modest protection against extrapulmonary TB. Preventative antibiotic treatment for Mycobacterium tuberculosis (Mtb) infections in high-prevalence settin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, C., Walzl, G., Du Plessis, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039813/ https://www.ncbi.nlm.nih.gov/pubmed/31772320 http://dx.doi.org/10.1038/s41385-019-0226-5

Ejemplares similares

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

Host-Directed Therapeutic Strategies for Tuberculosis
por: Kolloli, Afsal, et al.
Publicado: (2017)

Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis
por: Leukes, Vinzeigh N., et al.
Publicado: (2021)

Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
por: du Plessis, Nelita, et al.
Publicado: (2018)

Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium tuberculosis Infection
por: Adikesavalu, Harresh, et al.
Publicado: (2021)

The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
por: Eribo, Osagie A., et al.
Publicado: (2019)

Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts
por: Kotzé, Leigh A., et al.
Publicado: (2020)

Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology
por: Munansangu, Brian S. M., et al.
Publicado: (2022)

Phenotypic analysis of peripheral B cell populations during Mycobacterium tuberculosis infection and disease
por: du Plessis, Willem J., et al.
Publicado: (2016)

Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis
por: Boland, Ralf, et al.
Publicado: (2022)

Host-Directed Therapies for Tuberculosis
por: Jeong, Eui-Kwon, et al.
Publicado: (2022)

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis
por: du Plessis, Willem J., et al.
Publicado: (2016)

Host blood RNA signatures predict the outcome of tuberculosis treatment
por: Thompson, Ethan G., et al.
Publicado: (2017)

Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation
por: Ahmed, Sultan, et al.
Publicado: (2020)

Autophagy: A new strategy for host-directed therapy of tuberculosis
por: Paik, Seungwha, et al.
Publicado: (2018)

Potentials of Host-Directed Therapies in Tuberculosis Management
por: Dara, Yash, et al.
Publicado: (2019)

Manipulation of autophagy for host-directed tuberculosis therapy
por: Gina, P, et al.
Publicado: (2019)

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

Physicochemical and Biological Evaluation of Curdlan-Poly(Lactic-Co-Glycolic Acid) Nanoparticles as a Host-Directed Therapy Against Mycobacterium Tuberculosis
por: D’Souza, S, et al.
Publicado: (2022)

Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Diagnostic and Therapeutic Strategies for Peritoneal Tuberculosis: A Review
por: Wu, David C., et al.
Publicado: (2019)

Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
por: Kim, Jae-Sung, et al.
Publicado: (2020)

Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
por: Kiran, Dilara, et al.
Publicado: (2015)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Advancing host-directed therapy for tuberculosis: new therapeutic insights from the Toxoplasma gondii
por: Yang, Chul-Su
Publicado: (2017)

Culture filtrate supplementation can be used to improve Mycobacterium tuberculosis culture positivity for spinal tuberculosis diagnosis
por: Beltran, Caroline G. G., et al.
Publicado: (2022)

Advanced drug delivery and therapeutic strategies for tuberculosis treatment
por: Nair, Ayushi, et al.
Publicado: (2023)

All trans retinoic acid as a host-directed immunotherapy for tuberculosis
por: Bahlool, Ahmad Z., et al.
Publicado: (2022)

Utility of Host Markers Detected in Quantiferon Supernatants for the Diagnosis of Tuberculosis in Children in a High-Burden Setting
por: Chegou, Novel N., et al.
Publicado: (2013)

Differential Expression of Host Biomarkers in Saliva and Serum Samples from Individuals with Suspected Pulmonary Tuberculosis
por: Phalane, Khutso G., et al.
Publicado: (2013)

Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
por: Prussia, Andrew, et al.
Publicado: (2011)

Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection
por: Cerni, Stephen, et al.
Publicado: (2019)

Sinigrin and Its Therapeutic Benefits
por: Mazumder, Anisha, et al.
Publicado: (2016)

Directed evolution strategies for improved enzymatic performance
por: Hibbert, Edward G, et al.
Publicado: (2005)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Changes in Host Immune–Endocrine Relationships during Tuberculosis Treatment in Patients with Cured and Failed Treatment Outcomes
por: Kleynhans, Léanie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vfc11bmbb6q4ti9mf3d0okfff9